A Trial for a Personalized Medication Management Platform to Improve Medication Adherence

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

763 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-31

Study Completion Date

2012-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Taiwan has attracted much attention for its National Health Insurance (NHI) and healthcare system around the world with many countries in Europe and the United States using it as a benchmark. However, increasing medication costs over the past two years account for more than 25% of total expenditure, surpassing every OECD member and mounting increasing pressure on the NHI. Nevertheless, patient medication adherence is relatively low. Thus, the investigators assessed the effectiveness of a personalized medication management system for improving the medication adherence for patients, in order to save long term medication costs.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Medication Management Service

NCT06273761

Medication Adherence Medication Safety Diabetes Mellitus, Type 2 +3 more

RECRUITING NA

Reduce Medication Errors by Translating AESOP Model Into CPOE Systems

NCT03484793

Hypertension

COMPLETED NA

The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care

NCT01586897

Diabetes Mellitus, Type 2 Hypertension Hyperlipidemia

COMPLETED NA

Electronic Medication Adherence Reporting and Feedback During Care Transitions

NCT03475030

Medication Adherence

COMPLETED NA

Effect of an Electronic Reminder System on Direct Oral Anticoagulant and Oral Diabetes Medication Adherence

NCT03753568

Anticoagulant Drugs Diabetes Mellitus, Type 2

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Design, Setting and Patients: The investigators developed a mobile personalized medication management platform (PMMP) to reduce delayed and missed medications. The investigators conducted a randomized control trial in medical centers of northern Taiwan from January 2010 to July 2012 using 1198 participants that missed or delayed their medications during past three days. They received a minimum 7-day to 14-day maximum medication prescription.

Interventions: Patients were randomized into a control group which non-received any SMS reminder for medication using and an intervention group which received a SMS reminder everyday in mobile devices.

Primary Outcome(s) and Measure(s): The primary outcomes were compared patient medication adherence among experimental and control groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patients Take Medicine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SMS Medication Reminder

763 patients were assigned to experimental group

Group Type EXPERIMENTAL

Personalized Medication Management Platform for SMS Reminder

Intervention Type DEVICE

The Personalized Medication Management Platform was developed by investigators that integrated with Hospital Information System (HIS) to collect the prescription information of patients and automatically send SMS to remind

No SMS Reminder

435 patients were assigned to control group as no SMS reminder

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Personalized Medication Management Platform for SMS Reminder

The Personalized Medication Management Platform was developed by investigators that integrated with Hospital Information System (HIS) to collect the prescription information of patients and automatically send SMS to remind

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Delayed or forgot to take medications over the last 3 days
* Received a min. 7-day medication prescription
* Able to receive SMS using mobile phones / devices
* 20 years or older
* Having intention to receive active treatment

Exclusion Criteria

* Unable to receive SMS via mobile phones
* Illiterate and \< 20 years of age
* Received outpatient prescription drugs for ≤ 7 days
* External use, injections and traditional Chinese medicine
* Planned to go abroad
* Cold, cough, or prescribed with analgesics

Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No